Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Becton Dickinson and Company is a medical instruments & supplies business based in the US. Becton Dickinson and Company shares (BDX) are listed on the NYSE and all prices are listed in US Dollars. Becton Dickinson and Company employs 77,000 staff and has a trailing 12-month revenue of around $18.9 billion.
Finder Award
SoFi Invest
tastyworks
| Latest market close | $246.78 |
|---|---|
| 52-week range | $215.10 - $274.41 |
| 50-day moving average | $246.20 |
| 200-day moving average | $246.64 |
| Wall St. target price | $270.92 |
| PE ratio | 45.6784 |
| Dividend yield | $3.48 (1.48%) |
| Earnings per share (TTM) | $5.38 |
*Signup bonus information updated weekly.
Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $246.78 from 2023-01-25
| 1 week (2023-01-20) | -2.77% |
|---|---|
| 1 month (2022-12-27) | -3.34% |
| 3 months (2022-10-27) | 6.75% |
| 6 months (2022-07-27) | 1.00% |
| 1 year (2022-01-23) | N/A |
|---|---|
| 2 years (2021-01-27) | -1.64% |
| 3 years (2020-01-27) | 279.75 |
| 5 years (2018-01-26) | 0.20% |
Valuing Becton Dickinson and Company stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Becton Dickinson and Company's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Becton Dickinson and Company's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 46x. In other words, Becton Dickinson and Company shares trade at around 46x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Becton Dickinson and Company's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.3141. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Becton Dickinson and Company's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Becton Dickinson and Company's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $4.9 billion.
The EBITDA is a measure of a Becton Dickinson and Company's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $18.9 billion |
|---|---|
| Operating margin TTM | 13.96% |
| Gross profit TTM | $8.6 billion |
| Return on assets TTM | 3.08% |
| Return on equity TTM | 6.68% |
| Profit margin | 9.43% |
| Book value | $89.22 |
| Market capitalisation | $69.9 billion |
TTM: trailing 12 months
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Becton Dickinson and Company.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Total ESG risk: 33.76
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Becton Dickinson and Company's overall score of 33.76 (as at 12/31/2018) is pretty weak – landing it in it in the 65th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Becton Dickinson and Company is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Environmental score: 4.87/100
Becton Dickinson and Company's environmental score of 4.87 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson and Company is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Social score: 20.06/100
Becton Dickinson and Company's social score of 20.06 puts it squarely in the 5th percentile of companies rated in the same sector. This could suggest that Becton Dickinson and Company is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Governance score: 13.83/100
Becton Dickinson and Company's governance score puts it squarely in the 5th percentile of companies rated in the same sector. That could suggest that Becton Dickinson and Company is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Becton Dickinson and Company scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Becton Dickinson and Company hasn't always managed to keep its nose clean.
Becton Dickinson and Company was last rated for ESG on: 2019-01-01.
| Total ESG score | 33.76 |
|---|---|
| Total ESG percentile | 65.34 |
| Environmental score | 4.87 |
| Environmental score percentile | 5 |
| Social score | 20.06 |
| Social score percentile | 5 |
| Governance score | 13.83 |
| Governance score percentile | 5 |
| Level of controversy | 3 |
Dividend payout ratio: 28.6% of net profits
Recently Becton Dickinson and Company has paid out, on average, around 28.6% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 1.48% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Becton Dickinson and Company shareholders could enjoy a 1.48% return on their shares, in the form of dividend payments. In Becton Dickinson and Company's case, that would currently equate to about $3.48 per share.
While Becton Dickinson and Company's payout ratio might seem fairly standard, it's worth remembering that Becton Dickinson and Company may be investing much of the rest of its net profits in future growth.
Becton Dickinson and Company's most recent dividend payout was on 29 December 2022. The latest dividend was paid out to all shareholders who bought their shares by 7 December 2022 (the "ex-dividend date").
Becton Dickinson and Company's shares were split on a 1025:1000 basis on 31 March 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1025 shares. This wouldn't directly have changed the overall worth of your Becton Dickinson and Company shares – just the quantity. However, indirectly, the new 2.4% lower share price could have impacted the market appetite for Becton Dickinson and Company shares which in turn could have impacted Becton Dickinson and Company's share price.
Over the last 12 months, Becton Dickinson and Company's shares have ranged in value from as little as $215.1029 up to $274.4094. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Becton Dickinson and Company's is 0.5759. This would suggest that Becton Dickinson and Company's shares are less volatile than average (for this exchange).
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey. .
Everything we know about the TXO Energy IPO, plus information on how to buy in.
Everything we know about the Brera IPO, plus information on how to buy in.
What you need to know about investing in the leading indicator for the overall US stock market.
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
Your simple and straightforward guide to ETFs, how they work and the different types available.
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
Everything we know about the SONDORS IPO, plus information on how to buy in.
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
Learn about stock analysis and how to use it to find the right company to buy.
